Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy

Bioorganic and Medicinal Chemistry

Volumn 13, Issue 8, 2005, Pages 2799-2808

  Schneider, Raphaël ^a   Schmitt, Frédéric ^a   Frochot, Céline ^b   Fort, Yves ^a   Lourette, Natacha ^d   Guillemin, François ^c   Müller, Jean François ^d   Barberi Heyob, Muriel ^c  

^a NANCY UNIVERSITÉ   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CENTRE DE RECHERCHE EN AUTOMATIQUE DE NANCY   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Folic acid; Photodynamic therapy; Photophysical properties; Tetraphenylporphyrin

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; PHOTOSENSITIZING AGENT; TETRAPHENYLPORPHYRIN; UNCLASSIFIED DRUG; [GAMMA N [2 [2 (2 AMINOETHOXY)ETHOXY]ETHYL]FOLIC ACID] 4 CARBOXYPHENYLPORPHYRIN; [GAMMA(6 AMINOHEXYL)FOLIC ACID] 4 CARBOXYPHENYLPORPHYRIN;

ACTIVE TRANSPORT; ARTICLE; CARCINOMA CELL; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOCYTOSIS; FLUORESCENCE; HUMAN; HUMAN CELL; INCUBATION TIME; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM YIELD; ULTRAVIOLET SPECTROSCOPY;

EID: 15244354054     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2005.02.025     Document Type: Article

References (34)

1. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korberlik, J. Moan, and Q. Peng J. Natl. Cancer Inst. 90 1998 889
2. H.I. Pass J. Natl. Cancer Inst. 85 1993 443
3. G. Jori J. Photochem. Photobiol. B Biol. 36 1996 87
4. W.M. Sharman, J.E. Van Lier, and C.M. Allen Adv. Drug Delivery Rev. 56 2004 53
5. Y. Lu, and P.S. Low Adv. Drug Delivery Rev. 54 2002 675
6. C.P. Leamon, and P.S. Low Proc. Natl. Acad. Sci. U.S.A. 88 1991 5572
7. J.J. Turek, C.P. Leamon, and P.S. Low J. Cell Sci. 106 1993 423
8. B.A. Kamen, and A. Capdevila Proc. Natl. Acad. Sci. U.S.A. 83 1986 5983
9. C. Frochot, B. Di Stasio, M. Barberi-Heyob, M.C. Carré, J.M. Zwier, F. Guillemin, and M.L. Viriot Oftalmologia 56 2003 62
10. J.M. Saul, A. Annapragada, J.V. Natarajan, and R.V. Bellamkonda J. Controlled Release 92 2003 49
11. G.L. Stahl, R. Walter, and C.W. Smith J. Org. Chem. 43 1978 2285
12. C.P. Leamon, I. Pastan, and P.S. Low J. Biol. Chem. 269 1993 24847
13. S. Wang, J. Luo, D.A. Lantrip, D.J. Waters, C.J. Mathias, M.A. Green, P. Fuchs, and P.S. Low Bioconjugate Chem. 8 1997 673
14. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, F. Mandelbaum-Shavit, M.M. Qazen, and S. Zalipsky Bioconjugate Chem. 10 1999 289
15. S. Wang, R.J. Lee, C.J. Mathias, M.A. Green, and P.S. Low Bioconjugate Chem. 7 1996 56
16. M. Barberi-Heyob, P.O. Vedrine, J.L. Merlin, R. Millon, J. Abecassis, M.F. Poupon, and F. Guillemin Int. J. Oncol. 24 2004 951
17. R.J. Lee, and P.S. Low J. Biol. Chem. 269 1994 3168
18. C.P. Leamon, S.R. Copper, and G.E. Hardee Bioconjugate Chem. 14 2003 738
19. S. Wang, R.J. Lee, G. Cauchon, D.G. Gorenstein, and P.S. Low Proc. Natl. Acad. Sci. U.S.A. 92 1995 3318
20. Y. Lu, and P.S. Low J. Controlled Release 91 2003 17
21. J. Matulic-Adamic, M. Sanseverino, and L. Beigelman Tetrahedron Lett. 43 2002 4439
22. B.A. Gruner, and S.D. Weitman Invest. New Drugs 16 1998 205
23. G. Toffoli, A. Russo, A. Gallo, C. Cernigoi, S. Miotti, R. Sorio, S. Tumolo, and M. Boiocchi Int. J. Cancer 79 1998 121
24. J.F. Ross, H. Wang, F.G. Behm, P. Mathew, M. Wu, R. Booth, and M. Ratnam Cancer 85 1999 348
25. S. Wang, and P.S. Low J. Controlled Release 53 1998 39
26. W.A. Franklin, M. Waintrub, D. Edwards, K. Chistensen, P. Prendegrast, J. Woods, P.A. Bunn, and J.F. Kolhouse Int. J. Cancer 8 1994 89
27. M.D. Kennedy, K.N. Jallad, D.H. Thompson, D. Ben-Amotz, and P.S. Low J. Biomed. Opt. 8 2003 636
28. F. Shen, J.F. Ross, X. Wang, and M. Ratnam Biochemistry 33 1994 1209
29. I. Rosenthal Photochem. Photobiol. 53 1991 859
30. U. Isele, K. Schieweck, R. Kessler, P.V. Hoogevest, and H.G. Capraro J. Pharm. Sci. 84 1995 166
31. R. Hornung Curr. Drug Targets Immune Endocr. Metabol. Disord. 1 2001 165
32. C.B. Hansen, G.J. Hoogers, and W. Drenth J. Mol. Catal. 79 1993 153
33. J.F. Mirjolet, M. Barberi-Heyob, J.L. Merlin, S. Marchal, M.C. Etienne, G. Milano, and P. Bey Br. J. Cancer 78 1998 62
34. Chou, T. C.; Talalay, P. Application of the Median-Effect Principle for the Assessment of Low Dose Risk of Carcinogens & for the Quantification of Synergism & Antagonism of Chemotherapeutic Agents. In New Avenues in Developmental Cancer Chemotherapy; Harrap, K. R., Connors, T. A., Eds; NY; 1987: pp 37-64